Menu

Biology, Genetics & Bone Healing MCQs

Practice Set 39 of 212

This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.

Question 761

Topic: Biology, Genetics & Bone Healing

Recombinant human bone morphogenetic protein-2 (rhBMP-2) is utilized in orthopedic surgery for its potent osteoinductive properties. Upon binding to its specific transmembrane serine/threonine kinase receptors, rhBMP-2 induces bone formation via phosphorylation of which of the following intracellular signaling molecules?

. Smad 2 and 3
. Smad 1, 5, and 8
. JAK and STAT
. Beta-catenin
. NF-kappaB

Correct Answer & Explanation

. Smad 1, 5, and 8

Explanation

Bone Morphogenetic Proteins (BMPs), part of the TGF-beta superfamily, initiate intracellular signaling by binding to Type I and Type II serine/threonine kinase receptors. BMP signaling specifically causes the phosphorylation of receptor-regulated Smads 1, 5, and 8. These bind to the co-Smad (Smad 4) and translocate to the nucleus to induce osteogenic gene transcription (like Runx2). In contrast, TGF-beta signals primarily through Smad 2 and 3.

Question 762

Topic: Biology, Genetics & Bone Healing

Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL) is critical for osteoclast differentiation, activation, and survival. Which cell type is the primary endogenous source of RANKL in the bone microenvironment?

. Osteoclasts
. Osteoblasts
. Macrophages
. Chondrocytes
. Hematopoietic stem cells

Correct Answer & Explanation

. Osteoblasts

Explanation

Osteoblasts (and bone marrow stromal cells) are the primary source of RANKL. RANKL binds to the RANK receptor on osteoclast precursors (macrophage lineage), driving their differentiation and activation. Osteoprotegerin (OPG), also secreted by osteoblasts, acts as a decoy receptor to inhibit this process.

Question 763

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with knee pain. Radiographs reveal an eccentric, lytic lesion in the distal femoral epiphysis without a sclerotic margin. Biopsy shows multinucleated giant cells in a background of mononuclear stromal cells. The patient is treated with Denosumab prior to curettage. What is the mechanism of action of this medication?

. Inhibits RANK ligand (RANKL)
. Directly induces apoptosis of multinucleated giant cells
. Inhibits vascular endothelial growth factor (VEGF)
. Binds directly to the RANK receptor on osteoclast precursors
. Inhibits matrix metalloproteinases (MMPs) in the stroma

Correct Answer & Explanation

. Inhibits RANK ligand (RANKL)

Explanation

Denosumab is a human monoclonal antibody that specifically binds to and inhibits Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). In Giant Cell Tumor of bone, the neoplastic mononuclear stromal cells secrete excessive RANKL, which recruits and activates the reactive, bone-resorbing multinucleated giant cells. By blocking RANKL, Denosumab halts this process.

Question 764

Topic: Biology, Genetics & Bone Healing

Absolute stability constructs (e.g., lag screws and compression plates) in fracture fixation bypass the formation of a soft callus. Which of the following cell types plays the leading role in the 'cutting cone' phase of this specific type of bone healing?

. Chondrocytes
. Osteoclasts
. Fibroblasts
. Mesenchymal stem cells
. Macrophages

Correct Answer & Explanation

. Osteoclasts

Explanation

Absolute stability promotes primary (direct) bone healing, which occurs without the formation of a cartilaginous soft callus intermediate. This process relies on Haversian remodeling across the fracture site. The leading edge of this remodeling process is the 'cutting cone,' which is spearheaded by osteoclasts that bore through the dead cortical bone. They are followed closely by trailing osteoblasts that lay down new lamellar bone to bridge the gap.

Question 765

Topic: Biology, Genetics & Bone Healing

According to Perren's Strain Theory of bone healing, different tissues tolerate different amounts of interfragmentary strain before mechanical failure. Which of the following tissues can tolerate the highest percentage of strain?

. Lamellar bone
. Woven bone
. Fibrocartilage
. Granulation tissue
. Hyaline cartilage

Correct Answer & Explanation

. Granulation tissue

Explanation

Perren's strain theory dictates that a tissue cannot form if the local strain exceeds its tolerance. Granulation tissue tolerates the highest strain (up to 100%). Fibrocartilage tolerates roughly 10-15%, woven bone 2%, and lamellar bone only 1-2%. Initially, a fracture gap with high strain is filled with granulation tissue, which subsequently decreases the strain, allowing sequential formation of cartilage and ultimately bone.

Question 766

Topic: Biology, Genetics & Bone Healing

A 75-year-old male with a known history of Paget's disease of bone involving the left femur presents with new onset severe pain in the affected thigh, refractory to NSAIDs and bisphosphonates. Radiographs show progressive cortical thickening and bowing of the femur, with a new, subtle transverse lucency in the lateral cortex. What is the most appropriate next diagnostic step?

. CT scan of the femur.
. Bone scintigraphy (bone scan).
. MRI of the femur.
. Measurement of serum alkaline phosphatase levels.
. Biopsy of the lesion.

Correct Answer & Explanation

. MRI of the femur.

Explanation

This patient has Paget's disease affecting the femur and presents with new, severe pain and a 'subtle transverse lucency in the lateral cortex' on radiographs. This radiographic finding, especially in a pagetic bone that is bowed and hypertrophied, is highly suspicious for an impending or incomplete pathologic fracture, often referred to as a 'fissure fracture' or 'stress fracture' of Paget's bone. These fractures typically start on the convex side (tension side) of the bowed bone.Option A (CT scan) can provide more detailed bony architecture but may not be as sensitive for early stress fractures or soft tissue changes.Option B (Bone scintigraphy) would show increased uptake in the pagetic bone (hot spots), but it's a very sensitive but non-specific test. It might light up more intensely at the site of increased metabolic activity due to a stress fracture, but it wouldn't characterize the fracture line or any surrounding soft tissue injury as well as an MRI.Option C (MRI of the femur) is the most appropriate next diagnostic step. MRI is highly sensitive for detecting stress fractures, subtle lucencies, and incomplete fractures that may be missed or poorly characterized on plain radiographs or CT. It can also differentiate between different causes of pain (e.g., stress fracture, malignant transformation to sarcoma, inflammatory changes, or simply exacerbation of Paget's activity) and assess soft tissue involvement. Confirming an incomplete fracture or impending fracture is crucial for guiding management, often leading to prophylactic fixation.Option D (Measurement of serum alkaline phosphatase levels) is useful for monitoring disease activity in Paget's disease and response to bisphosphonates. However, it's a biochemical marker of bone turnover and will not directly diagnose or characterize a fracture. While a flare-up of Paget's could cause pain and elevate ALP, a new focal lucency points to a mechanical issue.Option E (Biopsy of the lesion) would be indicated if there was suspicion of malignant transformation (e.g., osteosarcoma, which is a known but rare complication of Paget's disease). While a new, severe pain can sometimes raise this concern, a 'subtle transverse lucency' is more characteristic of an incomplete fracture. MRI would be the first step to better characterize the lesion before considering an invasive biopsy.

Question 767

Topic: Biology, Genetics & Bone Healing

Regarding bone graft substitutes, which of the following statements accurately describes the primary characteristic of an osteoinductive material?

. It provides a scaffold for host bone to grow into.
. It stimulates mesenchymal stem cells to differentiate into osteoblasts.
. It mechanically supports the skeletal defect until healing occurs.
. It acts as a reservoir for growth factors that are slowly released.
. It enhances bone remodeling and resorption.

Correct Answer & Explanation

. It stimulates mesenchymal stem cells to differentiate into osteoblasts.

Explanation

Osteoinductive materials have the ability to stimulate mesenchymal stem cells (MSCs) to differentiate into osteoblasts, thereby inducing new bone formation, even in heterotopic sites. The classic example is bone morphogenetic protein (BMP). An osteoconductive material, on the other hand, provides a scaffold or framework for existing bone to grow into (e.g., calcium phosphate ceramics, demineralized bone matrix (DBM) primarily). Mechanical support is the role of structural grafts or fixation. Acting as a reservoir for growth factors might be a component of some advanced materials, but the direct stimulation of MSC differentiation is the core definition of osteoinduction. Enhancing bone remodeling and resorption is a metabolic function, not the primary characteristic of an osteoinductive graft.

Question 768

Topic: Biology, Genetics & Bone Healing

A 55-year-old female presents with widespread musculoskeletal pain, muscle weakness, and proximal leg cramps. She has a history of bariatric surgery 5 years prior. Biochemical tests reveal low serum calcium, low serum phosphate, elevated alkaline phosphatase, and elevated parathyroid hormone. Radiographs show Looser zones (pseudofractures) in the femoral neck and pubic rami. Which of the following is the MOST likely underlying diagnosis?

. Paget's disease of bone.
. Osteoporosis.
. Primary hyperparathyroidism.
. Vitamin D deficiency osteomalacia.
. Renal osteodystrophy.

Correct Answer & Explanation

. Vitamin D deficiency osteomalacia.

Explanation

The constellation of symptoms (widespread pain, weakness, cramps), history of bariatric surgery (which can lead to malabsorption), and biochemical findings (low calcium, low phosphate, elevated ALP, elevated PTH) strongly suggests vitamin D deficiency osteomalacia. The presence of Looser zones (pseudofractures) on radiographs is pathognomonic for osteomalacia. Paget's disease typically presents with localized pain, bone enlargement, and isolated elevated ALP but normal calcium/phosphate. Osteoporosis involves low bone mineral density and fragility fractures but not typically Looser zones or these specific biochemical abnormalities. Primary hyperparathyroidism causes hypercalcemia and hypophosphatemia, which is inconsistent with the low calcium. Renal osteodystrophy is seen in chronic kidney disease, which is not indicated here, though it shares some biochemical features.

Question 769

Topic: Biology, Genetics & Bone Healing

In the context of promoting bone healing, various orthobiologic agents are utilized. These agents exert their effects through different mechanisms. Which of the following orthobiologics primarily acts by providing a demineralized osteoconductive scaffold rich in growth factors to stimulate local mesenchymal stem cells, rather than directly supplying viable osteoprogenitor cells?

. Autogenous cancellous bone graft.
. Bone marrow aspirate concentrate (BMAC).
. Demineralized bone matrix (DBM).
. Platelet-rich plasma (PRP).
. Fresh frozen allograft.

Correct Answer & Explanation

. Demineralized bone matrix (DBM).

Explanation

Demineralized bone matrix (DBM) is processed allograft bone where the mineral component is removed, leaving behind the collagen matrix and non-collagenous proteins, including bone morphogenetic proteins (BMPs) and other growth factors. DBM primarily functions through osteoconduction (providing a scaffold for new bone formation) and osteoinduction (due to the retained growth factors that stimulate host mesenchymal stem cells). It does NOT contain viable osteoprogenitor cells, as these are destroyed during processing. Autogenous cancellous bone graft and Bone Marrow Aspirate Concentrate (BMAC) contain viable osteoprogenitor cells (osteogenesis). Platelet-rich plasma (PRP) primarily provides a high concentration of growth factors (osteoinduction) but does not provide a scaffold or viable cells. Fresh frozen allograft is primarily osteoconductive but lacks significant osteoinductive properties and viable cells.

Question 770

Topic: Biology, Genetics & Bone Healing

A 55-year-old patient with long-standing, poorly controlled type 2 diabetes presents with an acutely swollen, red, and warm left foot. Radiographs demonstrate early fragmentation and periarticular debris at the tarsometatarsal joints. Which of the following pro-inflammatory cytokines/pathways is considered the primary driver of osteoclastogenesis and bone resorption in the acute phase of Charcot neuroarthropathy?

. Transforming growth factor beta (TGF-b)
. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Bone morphogenetic protein-2 (BMP-2)
. Insulin-like growth factor-1 (IGF-1)
. Fibroblast growth factor (FGF)

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)

Explanation

The acute phase of Charcot neuroarthropathy is characterized by an exaggerated inflammatory response. The RANKL/OPG pathway is central to this process. Increased expression of pro-inflammatory cytokines (such as TNF-a and IL-1) stimulates the overexpression of RANKL. RANKL binds to RANK on osteoclast precursors, driving massive osteoclastogenesis and the rapid bone resorption/fragmentation pathognomonic of acute Charcot.

Question 771

Topic: Biology, Genetics & Bone Healing

Denosumab is increasingly utilized in the treatment of unresectable or recurrent Giant Cell Tumor (GCT) of bone. What is its exact mechanism of action?

. It binds to RANKL, preventing the activation of the RANK receptor
. It binds directly to the RANK receptor, inducing osteoclast apoptosis
. It inhibits osteoprotegerin (OPG), leading to osteoblast proliferation
. It binds directly to the multinucleated giant cells to halt mitosis

Correct Answer & Explanation

. It binds to RANKL, preventing the activation of the RANK receptor

Explanation

Denosumab is a fully human monoclonal antibody that binds specifically to Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By binding to RANKL, it prevents RANKL from interacting with the RANK receptor on the surface of osteoclast precursors and mature osteoclasts (and the giant cells in GCT), thereby inhibiting osteoclastogenesis and bone resorption.

Question 772

Topic: Biology, Genetics & Bone Healing

Demineralized bone matrix (DBM) is widely used as a bone graft substitute in spinal fusions. Based on its biological composition, which of the following properties does DBM possess?

. Osteoconduction and osteogenesis
. Osteoinduction only
. Osteoinduction and osteoconduction
. Osteogenesis only

Correct Answer & Explanation

. Osteoinduction and osteoconduction

Explanation

DBM possesses both osteoinductive and osteoconductive properties. It is osteoinductive because the acid-demineralization process exposes growth factors, primarily Bone Morphogenetic Proteins (BMPs). It is osteoconductive because the remaining Type I collagen provides a structural scaffold for new bone growth. It is NOT osteogenic because it lacks living cells (osteoblasts/osteoprogenitor cells).

Question 773

Topic: Biology, Genetics & Bone Healing

A 65-year-old female presents with severe thoracic back pain, fatigue, and anemia. Workup reveals multiple lytic bone lesions without sclerotic rims. Which cytokine is primarily responsible for the marked osteoclast activation and resulting osteolytic lesions in this disease process?

. Interleukin-1 (IL-1)
. Interleukin-6 (IL-6)
. Tumor Necrosis Factor-alpha (TNF-alpha)
. Transforming Growth Factor-beta (TGF-beta)

Correct Answer & Explanation

. Interleukin-6 (IL-6)

Explanation

The patient has Multiple Myeloma. The myeloma cells secrete high levels of Interleukin-6 (IL-6), which acts as a potent stimulator of osteoclastogenesis via the RANK/RANKL pathway, leading to massive bone resorption (lytic lesions). Additionally, osteoblast function is inhibited.

Question 774

Topic: Biology, Genetics & Bone Healing

In the pathogenesis of aseptic loosening following total joint arthroplasty, submicron particulate polyethylene debris is generated and subsequently phagocytosed by local macrophages. Which of the following is the primary downstream effector cell directly responsible for the resulting periprosthetic bone resorption (osteolysis)?

. T-lymphocyte
. Osteoblast
. Osteoclast
. Fibroblast

Correct Answer & Explanation

. Osteoclast

Explanation

The biological response to wear debris is macrophage-mediated. Macrophages phagocytose the polyethylene particles and release pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6). These cytokines upregulate RANKL expression, which stimulates the final effector cell—the osteoclast—to resorb periprosthetic bone, leading to aseptic loosening.

Question 775

Topic: Biology, Genetics & Bone Healing

A 30-year-old woman presents with knee pain. Radiographs show an eccentric, lytic epiphyseal lesion in the distal femur. Biopsy confirms a Giant Cell Tumor (GCT) of bone.

Denosumab is considered for neo-adjuvant treatment to consolidate the tumor rim. What is the specific cellular target of denosumab in the pathogenesis of this tumor?

. The RANK receptor on the surface of the multinucleated giant cells.
. The RANK Ligand (RANKL) produced by the neoplastic mononuclear stromal cells.
. Osteoprotegerin (OPG) produced by local osteoblasts.
. Vascular Endothelial Growth Factor (VEGF) expressed by the tumor vasculature.
. The tyrosine kinase receptor on the neoplastic giant cells.

Correct Answer & Explanation

. The RANK Ligand (RANKL) produced by the neoplastic mononuclear stromal cells.

Explanation

In Giant Cell Tumor of bone, the true neoplastic cells are the mononuclear spindle-like stromal cells, not the giant cells. These stromal cells secrete large amounts of RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). The RANKL recruits and activates normal osteoclast precursors to fuse into the characteristic reactive, bone-destroying multinucleated giant cells. Denosumab is a monoclonal antibody that specifically binds to and inhibits RANKL.

Question 776

Topic: Biology, Genetics & Bone Healing

Which of the following statements correctly describes the cellular pathophysiology of a Giant Cell Tumor (GCT) of bone?

. Multinucleated giant cells are the primary neoplastic cells and express RANK.
. Mononuclear stromal cells are the primary neoplastic cells and express RANKL.
. Multinucleated giant cells express RANKL to recruit reactive mononuclear cells.
. The tumor is driven by an overproduction of osteoprotegerin (OPG).
. Denosumab directly induces apoptosis in the multinucleated giant cells.

Correct Answer & Explanation

. Mononuclear stromal cells are the primary neoplastic cells and express RANKL.

Explanation

In Giant Cell Tumor of bone, the mononuclear stromal cells are the true neoplastic cells. They express Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL), which recruits and activates the reactive multinucleated osteoclast-like giant cells that cause bone destruction.

Question 777

Topic: Biology, Genetics & Bone Healing

A patient sustains an isolated, closed transverse fracture of the humeral shaft. During non-operative management with a functional brace, primary healing occurs via endochondral ossification. If rigid internal fixation with a compression plate had been used instead, bone healing would primarily depend on which of the following cellular processes?

. Formation of a soft cartilage callus
. Osteoclastic cutting cones crossing the fracture site
. Proliferation of periosteal stem cells without osteoclasts
. Differentiation of mesenchymal cells into chondrocytes
. Secretion of matrix metalloproteinases by macrophages

Correct Answer & Explanation

. Osteoclastic cutting cones crossing the fracture site

Explanation

Rigid internal fixation with absolute stability (such as a compression plate for a transverse fracture) promotes primary bone healing. This occurs via direct Haversian remodeling driven by osteoclastic cutting cones, bypassing the formation of a cartilaginous soft callus seen in secondary healing.

Question 778

Topic: Biology, Genetics & Bone Healing



A 28-year-old female presents with a lytic lesion in her distal femur abutting the joint. Biopsy confirms a Giant Cell Tumor of bone. She is treated with Denosumab prior to surgery. What is the mechanism of action of Denosumab, and what is the characteristic histological change seen after treatment?

. Inhibits RANK; increases osteoclast apoptosis.
. Binds RANKL; elimination of multinucleated giant cells and formation of woven bone.
. Binds osteoprotegerin; increased calcification of tumor matrix.
. Tyrosine kinase inhibitor; central necrosis of the tumor.
. Binds RANKL; proliferation of mononuclear spindle cells.

Correct Answer & Explanation

. Binds RANKL; elimination of multinucleated giant cells and formation of woven bone.

Explanation

Denosumab is a monoclonal antibody that binds to RANKL, preventing it from interacting with RANK on osteoclasts and osteoclast-like giant cells. In Giant Cell Tumor of bone, it leads to a dramatic depletion of the multinucleated giant cells, leaving behind a fibrous stroma and resulting in dense woven bone formation and peripheral rimming.

Question 779

Topic: Biology, Genetics & Bone Healing

Recombinant human bone morphogenetic proteins (rhBMPs) are commonly used to enhance bone healing. Which specific intracellular signaling molecules are directly phosphorylated by the BMP receptor complex to translocate to the nucleus and activate osteogenic gene transcription?

. JAK/STAT
. Smad 1, 5, and 8
. Wnt/beta-catenin
. MAPK/ERK
. NFATc1

Correct Answer & Explanation

. Smad 1, 5, and 8

Explanation

BMPs bind to serine/threonine kinase receptors that phosphorylate receptor-regulated Smads (Smad 1, 5, and 8). These then form a complex with Smad 4, which translocates to the nucleus to regulate transcription of osteogenic genes.

Question 780

Topic: Biology, Genetics & Bone Healing

Denosumab is increasingly used as a targeted medical therapy for the treatment of giant cell tumor of bone. By which specific mechanism does this monoclonal antibody halt tumor progression?

. Inhibiting the Wnt/beta-catenin pathway in osteoblasts
. Binding to RANK ligand to prevent osteoclast activation
. Directly inducing apoptosis of the neoplastic stromal cells
. Blocking vascular endothelial growth factor (VEGF) receptors
. Antagonizing parathyroid hormone-related peptide (PTHrP)

Correct Answer & Explanation

. Binding to RANK ligand to prevent osteoclast activation

Explanation

Denosumab binds directly to RANKL, preventing it from interacting with RANK on the surface of osteoclast precursors. In giant cell tumors, this stops the neoplastic stromal cells from recruiting and activating the destructive multinucleated giant cells.

Test Yourself

Switch to an interactive, timed exam simulation to truly master this topic.

On this Page